Company profile
Elenae Therapeutics, Inc.
- Industry
- Biotechnology Research
- Employees
- 2
- Headquarters
- Berkeley, California
- Founded
- 2021
- LinkedIn followers
- 245
- Office locations
- 1
Elenae Therapeutics, Inc. company summary
Elenae Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Berkeley, California, founded in 2021. On LinkedIn the company has around 2 employees and 245 followers.
What technology does Elenae Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Elenae Therapeutics, Inc.
Elenae Therapeutics, Inc. is a platform RNA Medicine company with cutting-edge AI-designed antisense oligonucleotide (ASO) technology that can target and penetrate tissues not previously thought accessible to ASOs, including heart, skeletal muscle, retina, and lung, with an excellent safety profile. Elenae is initially targeting microRNAs identified as major pathological contributors to several aging-related diseases that limit healthspan (heart failure, dry age-related macular degeneration (AMD), and aging-related sarcopenia), as well as rare diseases such as Duchenne and Becker muscular dystrophies. The modality is based on locked nucleic acid (LNA) ASO mixmers with a phosphorothioate (PS) backbone, delivered once-weekly to once-monthly subcutaneously in saline. There is strong efficacy and safety data in mice, pigs and/or NHPs for all indications. Elenae was founded in 2021 by Anders M. Näär, PhD, Professor of Metabolic Biology at University of California, Berkeley. Elenae is housed in the Bakar Labs biotech incubator next to the UC Berkeley campus. Prof. Näär is on leave of absence and serving as full time CEO, and an ASO drug development team is in place.
Where is Elenae Therapeutics, Inc. located?
Elenae Therapeutics, Inc. lists 1 location.
Compare companies similar to Elenae Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Elenae Therapeutics, Inc. elenaetherapeutics.com | Biotechnology Research | 2 | 2021 | Berkeley, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Elenae Therapeutics, Inc.
What does Elenae Therapeutics, Inc. do?
Elenae Therapeutics, Inc. is a platform RNA Medicine company with cutting-edge AI-designed antisense oligonucleotide (ASO) technology that can target and penetrate tissues not previously thought accessible to ASOs, including heart, skeletal muscle, retina, and lung, with an excellent safety profile. Elenae is initially targeting microRNAs identified as major pathological contributors to several aging-related diseases that limit healthspan (heart failure, dry age-related macular degeneration (AMD), and aging-related sarcopenia), as well as rare diseases such as Duchenne and Becker muscular dystrophies. The modality is based on locked nucleic acid (LNA) ASO mixmers with a phosphorothioate (PS) backbone, delivered once-weekly to once-monthly subcutaneously in saline. There is strong efficacy and safety data in mice, pigs and/or NHPs for all indications. Elenae was founded in 2021 by Anders M. Näär, PhD, Professor of Metabolic Biology at University of California, Berkeley. Elenae is housed in the Bakar Labs biotech incubator next to the UC Berkeley campus. Prof. Näär is on leave of absence and serving as full time CEO, and an ASO drug development team is in place.
How many employees does Elenae Therapeutics, Inc. have?
Elenae Therapeutics, Inc. has around 2 employees on LinkedIn.
Where is Elenae Therapeutics, Inc. headquartered?
Elenae Therapeutics, Inc. is headquartered in Berkeley, California.
When was Elenae Therapeutics, Inc. founded?
Elenae Therapeutics, Inc. was founded in 2021.
Build a lead list from companies like Elenae Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.